subject: CHEBI:79699

object_name: uterine carcinosarcoma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: ovarian serous surface papillary adenocarcinoma

tested_intervention: unsure


subject: CHEBI:79699

object_name: Regional Digestive System Neuroendocrine Tumor G1


subject: CHEBI:79699

object_name: Recurrent Digestive System Neuroendocrine Tumor G1

tested_intervention: yes


subject: CHEBI:79699

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: CHEBI:79699

object_name: PPoma


subject: CHEBI:79699

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:79699

object_name: Pancreatic Beta Cell Adenoma


subject: CHEBI:79699

object_name: Pancreatic Delta Cell Adenoma


subject: CHEBI:79699

object_name: Pancreatic Alpha Cell Adenoma


subject: CHEBI:79699

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:79699

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:79699

object_name: Stage IIIA Uterine Corpus Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIB Uterine Corpus Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IIIC Uterine Corpus Cancer AJCC v7


subject: CHEBI:79699

object_name: Malignant Pancreatic Somatostatinoma


subject: CHEBI:79699

object_name: Stage IVB Uterine Corpus Cancer AJCC v7


subject: CHEBI:79699

object_name: Stage IVA Uterine Corpus Cancer AJCC v7


subject: CHEBI:79699

object_name: Pancreatic G-Cell Adenoma


subject: CHEBI:79699

object_name: Malignant gastrinoma of pancreas


subject: CHEBI:79699

object_name: Malignant Pancreatic Insulinoma


subject: CHEBI:79699

object_name: Glucagonoma, malignant


subject: UMLS:C4723695

subject_name: penpulimab

object_name: MGMT-Unmethylated Glioblastoma


subject: UNII:GKF8S4C432

subject_name: Anlotinib


subject: CHEBI:45783

subject_name: Imatinib

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:45783

object_name: pulmonary hypertension


subject: CHEBI:45783

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:45783

object_name: pulmonary arterial hypertension


subject: CHEBI:6121

subject_name: Ketamine

object_name: Chronic cough


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Frailty


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW

object_name: AIDS-related primary central nervous system lymphoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:85154

subject_name: Akynzeo

object_name: cervical cancer


subject: CHEBI:85154

object_name: cervical carcinoma


subject: CHEBI:85154

object_name: adverse effect


subject: RXCUI:1552339

subject_name: netupitant / palonosetron Oral Product


subject: RXCUI:1552339


subject: RXCUI:1552339


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Non-small cell lung cancer recurrent


subject: UMLS:C5848866

object_name: Activating EGFR Gene Mutation


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:24956525


subject: PUBCHEM.COMPOUND:24956525


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: UMLS:C1268567


subject: UMLS:C1268567


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: Plasmodium falciparum malaria


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:74073

subject_name: Ile-Met

object_name: HIV infection


subject: CHEBI:30366

subject_name: imidazolide


subject: CHEBI:32139

object_name: Cognitive impairment


subject: UMLS:C5882212

object_name: kidney failure


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:9831414

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:9831414

object_name: Atrial Fibrillation, CTCAE


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEBI:94534

subject_name: olanzapine

object_name: endogenous depression


subject: CHEBI:94534

object_name: major depressive disorder


subject: UMLS:C5237036

subject_name: Docetaxel Polymeric Micelles

object_name: head and neck squamous cell carcinoma


subject: UNII:H57D26Z9YK

subject_name: remestemcel-l

object_name: Crohn's colitis


subject: DRUGBANK:DB18032

subject_name: Allogenic bone marrow-derived mesenchymal stem cells


subject: DRUGBANK:DB17478

object_name: non-small cell lung carcinoma


subject: PR:000001711

subject_name: trace amine-associated receptor 1


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: essential hypertension


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:142432

subject_name: Vericiguat

object_name: metabolic disease


subject: CHEBI:142432

object_name: insulin sensitivity/resistance


subject: CHEBI:142432

object_name: cardiovascular disorder


subject: CHEBI:142432

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:142432

object_name: obesity


subject: CHEBI:142432

object_name: Obesity, CTCAE


subject: CHEBI:17688

subject_name: Nicotine

object_name: euthyroid Graves orbitopathy


subject: CHEBI:17688

object_name: endocrine exophthalmos


subject: CHEBI:84739

object_name: cystic fibrosis


subject: CHEBI:2637

subject_name: Amikacin


subject: UMLS:C0591279

subject_name: Colomycin


subject: MESH:C587694

object_name: colorectal cancer


subject: MESH:C587694

object_name: colorectal carcinoma


subject: MESH:C587694

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3180100

object_name: alcohol abuse


subject: UMLS:C3180100

object_name: alcohol dependence


subject: UMLS:C0700805

subject_name: Fludara

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:3441

subject_name: Carvedilol

object_name: type 2 diabetes mellitus


subject: CHEBI:3441

object_name: Diabetes


subject: CHEBI:3441

object_name: diabetes mellitus


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: end stage renal failure


subject: UNII:J2L7Z273SG

object_name: Solid Neoplasm


subject: UNII:J2L7Z273SG

object_name: low grade glioma


subject: UMLS:C5854744

subject_name: Plixorafenib


subject: UMLS:C5854744


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: food allergy


subject: CHEBI:73604

object_name: hemophilia B


subject: CHEBI:73604

object_name: hemophilia B leyden


subject: CHEBI:36706

subject_name: Resiquimod

object_name: neoplasm


subject: UNII:9J765S329G

subject_name: L-Thyroxine sodium salt pentahydrate

object_name: hypothyroidism


subject: UNII:9J765S329G

object_name: Hypothyroidism, CTCAE


subject: CHEBI:6447

subject_name: levothyroxine sodium hydrate


subject: CHEBI:6447


subject: UMLS:C0079691

subject_name: Levothroid


subject: UMLS:C0079691


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Effects of chemotherapy


subject: CHEBI:75179

object_name: breast neoplasm


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:74947

subject_name: Thalidomide

object_name: carcinosarcoma of the corpus uteri


subject: CHEBI:74947

object_name: uterine carcinosarcoma


subject: CHEBI:74947

object_name: Recurrent Uterine Corpus Sarcoma


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: antibiotic side-effect


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: PUBCHEM.COMPOUND:1549163

subject_name: Silybin

object_name: hypertension


subject: PUBCHEM.COMPOUND:1549163

object_name: Hypertension, CTCAE


subject: CHEBI:9144

subject_name: Silibinin


subject: CHEBI:9144


subject: CHEBI:172705

subject_name: DEHYDROSILYLBIN


subject: CHEBI:172705


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:36796

subject_name: duloxetine

object_name: diabetic neuropathy


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:3160

subject_name: botulinum toxin type A


subject: CHEBI:157802

subject_name: Cys-Arg


subject: CHEBI:157802


subject: CHEBI:157802

object_name: type 2 diabetes mellitus


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:28073


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:49544


subject: PR:000004968

subject_name: calretinin


subject: PR:000004968


subject: PR:000004968


subject: PR:000006466

subject_name: dehydrogenase/reductase SDR family member 4


subject: PR:000006466


subject: PR:000006466


subject: PR:000025662

subject_name: complement decay-accelerating factor


subject: PR:000025662


subject: PR:000025662


subject: UniProtKB:Q8VHX2

subject_name: EDAD_MOUSE Ectodysplasin-A receptor-associated adapter protein (sprot)


subject: UniProtKB:Q8VHX2


subject: UniProtKB:Q8VHX2


subject: PR:000006889

subject_name: ectodysplasin-A receptor-associated adapter protein


subject: PR:000006889


subject: PR:000006889


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Mechanical ventilation complication


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: PR:000011500

subject_name: kinetochore protein Nuf2

object_name: non-small cell lung carcinoma


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: Dupuytren's disease of finger


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: PUBCHEM.COMPOUND:71622431

subject_name: ivarmacitinib

object_name: ankylosing spondylitis


subject: UMLS:C5565994


subject: UMLS:C5554858

subject_name: SARS-CoV-2 mRNA Vaccine ARCT-021


subject: UMLS:C5554858

object_name: Coronavinae infectious disease


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: granulocytic sarcoma


subject: UNII:7CND0TX59N

object_name: myeloid sarcoma


subject: UNII:7CND0TX59N

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:28837

subject_name: Caprylic acid


subject: CHEBI:28837


subject: CHEBI:28837


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: PUBCHEM.COMPOUND:5458171


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:84500

subject_name: varenicline

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:84500


subject: CHEBI:84507

subject_name: Chantix


subject: CHEBI:84507


subject: PUBCHEM.COMPOUND:46874763

object_name: urinary tract infection


subject: PUBCHEM.COMPOUND:46874763

object_name: Recurrent urinary tract infections


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0304926

subject_name: human plasma preparation

object_name: Hemorrhagic Shock


subject: UMLS:C0304926

object_name: blood coagulation disease


subject: UMLS:C0304926

object_name: aortic aneurysm


subject: UMLS:C0304926

object_name: Physical trauma


subject: UMLS:C0304926

object_name: Injury


subject: UMLS:C0304926

object_name: Trauma


subject: CHEBI:9288

subject_name: Streptozocin

object_name: Hyperkalemia, CTCAE


subject: CHEBI:9288

object_name: Hyperkalemia


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: plasma cell myeloma


subject: CHEBI:44915

subject_name: Propofol

object_name: pulmonary hypertension


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:91090

subject_name: charcoal

object_name: asthma


subject: CHEBI:27594

subject_name: Graphite


subject: CHEBI:50853

subject_name: quantum dot

object_name: esophageal adenocarcinoma


subject: CHEBI:50853

object_name: lung adenocarcinoma


subject: CHEBI:50853

object_name: cervical adenocarcinoma


subject: CHEBI:50853

object_name: adenocarcinoma


subject: CHEBI:50853

object_name: bile duct adenocarcinoma


subject: CHEBI:50853

object_name: gastric adenocarcinoma


subject: CHEBI:50853

object_name: pancreatic ductal adenocarcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: biliary atresia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:2663

subject_name: Amiodarone

object_name: persistent atrial fibrillation


subject: CHEBI:2663

object_name: Persistent Atrial Fibrillation by ECG Finding


subject: CHEBI:70839

subject_name: Dasatinib

object_name: metastatic melanoma


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: respiratory tract infectious disorder


subject: CHEBI:3614

object_name: pneumonia


subject: CHEBI:3614

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:50853

object_name: Heartburn


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Advanced Colorectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: RXCUI:2648470

subject_name: mometasone furoate Nasal Spray

object_name: perennial allergic rhinitis


subject: UMLS:C5139693

subject_name: Pegbelfermin

object_name: Liver Fibrosis


subject: UMLS:C5139693

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C5139942


subject: UMLS:C5139942


subject: UMLS:C0061830

object_name: HIV Seronegativity


subject: MESH:C089950

subject_name: MF59 oil emulsion


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Polypoidal choroidal vasculopathy


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:8228

object_name: obesity


subject: CHEBI:8228

object_name: Obesity, CTCAE


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: coronary atherosclerosis


subject: CHEBI:231614

subject_name: Nivolumab

object_name: DNA Breaks, Double-Stranded


subject: CHEBI:231614

object_name: DNA Damage


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:181992

object_name: Recurrent respiratory tract infections


subject: CHEBI:94618

subject_name: Pidotimod


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: Compensated hypothyroidism


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:63632

subject_name: Topotecan

object_name: non-small cell lung carcinoma


subject: CHEBI:63632

object_name: cervical polyp


subject: CHEBI:63632

object_name: neuroendocrine carcinoma


subject: UMLS:C3896746

object_name: small cell lung carcinoma


subject: UMLS:C3896746


subject: UMLS:C3896746


subject: UMLS:C3896746


subject: UMLS:C3896746

object_name: ovarian cancer


subject: UMLS:C3896746

object_name: ovarian neoplasm


subject: UMLS:C4724802


subject: UMLS:C4724802


subject: UMLS:C4724802


subject: UMLS:C4724802


subject: UMLS:C4724802


subject: UMLS:C4724802


subject: UMLS:C0812987

subject_name: Chemotherapy Drugs Adminstered

object_name: Carcinoma breast stage IV


subject: CHEBI:52763

object_name: schizophrenia


subject: CHEBI:52763

object_name: schizoaffective disorder


subject: CHEBI:52763

object_name: schizophrenia 18


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: plasma cell myeloma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UNII:7N13IK9LNH

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:7N13IK9LNH

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UNII:7N13IK9LNH

object_name: Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UNII:7N13IK9LNH

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:7N13IK9LNH

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:7N13IK9LNH

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:7N13IK9LNH

object_name: Unresectable Laryngeal Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UNII:7N13IK9LNH

object_name: Unresectable Oral Cavity Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Unresectable Salivary Gland Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:7N13IK9LNH

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:7N13IK9LNH

object_name: Unresectable Oropharyngeal Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Unresectable Hypopharyngeal Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Recurrent Paranasal Sinus Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Unresectable Paranasal Sinus Squamous Cell Carcinoma


subject: UNII:7N13IK9LNH

object_name: Recurrent Salivary Gland Cancer


subject: UNII:7N13IK9LNH

object_name: Stage IV Major Salivary Gland Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Major Salivary Gland Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UNII:7N13IK9LNH

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:7N13IK9LNH

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: DRUGBANK:DB19041

subject_name: Elimusertib

object_name: Squamous cell carcinoma of head and neck recurrent


subject: DRUGBANK:DB19041

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: DRUGBANK:DB19041

object_name: Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: DRUGBANK:DB19041

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: DRUGBANK:DB19041

object_name: Laryngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB19041

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: DRUGBANK:DB19041

object_name: Unresectable Laryngeal Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: DRUGBANK:DB19041

object_name: Unresectable Oral Cavity Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Unresectable Salivary Gland Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB19041

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: DRUGBANK:DB19041

object_name: Unresectable Oropharyngeal Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Unresectable Hypopharyngeal Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Recurrent Paranasal Sinus Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Unresectable Paranasal Sinus Squamous Cell Carcinoma


subject: DRUGBANK:DB19041

object_name: Recurrent Salivary Gland Cancer


subject: DRUGBANK:DB19041

object_name: Stage IV Major Salivary Gland Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Major Salivary Gland Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Laryngeal Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: DRUGBANK:DB19041

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: DRUGBANK:DB19041

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UNII:DPT0O3T46P

object_name: Unresectable Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UNII:DPT0O3T46P

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: UNII:DPT0O3T46P

object_name: Unresectable Laryngeal Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Unresectable Oral Cavity Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Unresectable Salivary Gland Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Unresectable Oropharyngeal Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Unresectable Hypopharyngeal Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Paranasal Sinus Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Unresectable Paranasal Sinus Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Salivary Gland Cancer


subject: UNII:DPT0O3T46P

object_name: Stage IV Major Salivary Gland Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Major Salivary Gland Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Arthrofibrosis


subject: CHEBI:17650

object_name: osteoarthritis, knee


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Childhood Solid Neoplasm


subject: UNII:6A901E312A

object_name: Adult Solid Neoplasm


subject: UNII:6A901E312A

object_name: Solid Neoplasm


subject: UNII:6A901E312A

object_name: pancreatic ductal adenocarcinoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: nervous system cancer


subject: UNII:2S9ZZM9Q9V

object_name: glioma


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: cocaine abuse


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Epiphysiolysis


subject: CHEBI:64356

object_name: Nerve Pain


subject: CHEBI:23359

subject_name: colchicine

object_name: Behcet disease


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: endometrium adenocarcinoma


subject: CHEBI:6715

object_name: Stage I Uterine Corpus Cancer


subject: CHEBI:6715

object_name: Stage II Uterine Corpus Cancer


subject: CHEBI:6715

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:6715

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:6715

object_name: endometrial adenosquamous carcinoma


subject: UNII:VT3A7NA96K

object_name: Plasmodium falciparum malaria


subject: UNII:VT3A7NA96K

object_name: Malaria, Vivax


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Inappropriate sinus tachycardia


subject: CHEBI:25681

object_name: Inappropriate Sinus Tachycardia by ECG Finding


subject: UMLS:C2933332

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C2933332

object_name: pancreatic neoplasm


subject: UMLS:C2933332

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2933332

object_name: malignant pancreatic neoplasm


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Cervical high grade squamous intraepithelial lesion


subject: UMLS:C3257082

subject_name: Fish extract

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C3257082

object_name: metabolic syndrome X


subject: UMLS:C3257082

object_name: Prediabetes


subject: UMLS:C3257082

object_name: glucose intolerance


subject: UMLS:C3257082

object_name: Impaired glucose tolerance


subject: UMLS:C3257082

object_name: Impaired fasting glucose


subject: UMLS:C3257082

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C3257082

object_name: obesity


subject: UMLS:C3257082

object_name: Obesity, CTCAE


subject: PR:000014829

subject_name: SH3 and PX domain-containing protein 2A


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: PR:000014829


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: glioblastoma


subject: CHEBI:68646

object_name: Brain Stem Glioblastoma


subject: CHEBI:68646

object_name: glioma susceptibility 1


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: UMLS:C1314954

subject_name: Pituitary Adenylate Cyclase Activating Polypeptide 38

object_name: Headache


subject: UMLS:C1314954

object_name: Headache, CTCAE


subject: UMLS:C1314954

object_name: migraine


subject: UMLS:C1314954

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:5441

subject_name: Glyburide


subject: CHEBI:5441


subject: CHEBI:5441


subject: CHEBI:5441


subject: CHEBI:149504

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Acute respiratory tract infection


subject: CHEBI:89324

object_name: Recurrent acute respiratory tract infection


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:17780

subject_name: Oxitriptan

object_name: irritable bowel syndrome


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Metastatic malignant neoplasm to bone


subject: UNII:28X28X9OKV

object_name: node; prostate


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: Iron deficiency anemia of pregnancy


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: stroke disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: cerebrovascular disorder


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Stroke (heart beat)


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Stroke, CTCAE


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: CHEBI:89324


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: MESH:C000654487

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:128886

object_name: hypertension


subject: PUBCHEM.COMPOUND:128886

object_name: Heart failure NYHA class III


subject: PUBCHEM.COMPOUND:128886

object_name: Heart failure NYHA class IV


subject: PUBCHEM.COMPOUND:128886

object_name: diabetes mellitus


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: complex regional pain syndrome


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Adult Primary Cutaneous Anaplastic Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: primary cutaneous anaplastic large cell lymphoma


subject: UNII:7XL5ISS668

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:7XL5ISS668

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:6931

subject_name: Midazolam

object_name: acute myocardial infarction


subject: CHEBI:6931

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:6413

subject_name: Letrozole

object_name: Medical abortion, complete or unspecified, without complication


subject: CHEBI:32260

subject_name: Trilostane


subject: CHEBI:42588

subject_name: Fenretinide

object_name: bladder tumor


subject: CHEBI:42588

object_name: urinary bladder carcinoma


subject: CHEBI:42588

object_name: urinary bladder cancer


subject: CHEBI:42588

object_name: childhood bladder carcinoma


subject: CHEBI:135954

subject_name: Bilastine

object_name: chronic urticaria


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: perinatal asphyxia


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:GE2T1418SV

subject_name: Umeclidinium

object_name: Hyperhidrosis, CTCAE


subject: UNII:GE2T1418SV

object_name: Hyperhidrosis


subject: UMLS:C5433389

object_name: chronic kidney disease


subject: UMLS:C5433389

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Influenza due to Influenza virus, type B


subject: UMLS:C0085297

object_name: influenza A


subject: CHEBI:48273

subject_name: Rizatriptan

object_name: migraine


subject: CHEBI:48273

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C5203351

subject_name: Furosemide Liquid Injection

object_name: Delayed Graft Function


subject: UMLS:C5203351

object_name: Disorder of transplanted kidney


subject: UMLS:C4048177

subject_name: furosemide injection


subject: UMLS:C4048177


subject: CHEBI:47426

subject_name: Furosemide


subject: CHEBI:135272

subject_name: Etifoxine

object_name: multiple sclerosis


subject: UMLS:C1611320


subject: UMLS:C5239491

subject_name: Aqualief

object_name: outcomes general quality of life


subject: UMLS:C5239491

object_name: Perceived quality of life


subject: UMLS:C5239491

object_name: Good quality of life


subject: UMLS:C5239491

object_name: Xerostomia due to hyposecretion of salivary gland


subject: UMLS:C5239491

object_name: Poroid Hidradenoma


subject: UMLS:C5239491

object_name: progestogen hypersensitivity


subject: UMLS:C5239491

object_name: Philadelphia Chromosome


subject: UMLS:C5239491

object_name: Past history of


subject: UMLS:C5239491

object_name: Infusion pump Alert priority PH


subject: UMLS:C5239491

object_name: Finding of pH


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: diffuse large B-cell lymphoma


subject: CHEBI:5864

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:5864

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: ocular hypertension


subject: CHEBI:51230

object_name: Ocular hypertension


subject: CHEBI:51230

object_name: open-angle glaucoma


subject: UMLS:C2713627

subject_name: Revolade

object_name: Myelodysplasia


subject: UMLS:C2713627

object_name: thrombocytopenia


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: Heart failure with normal ejection fraction


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: Estrogen receptor positive tumor


subject: CHEBI:50790

object_name: Early Stage Breast Carcinoma


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:41774

subject_name: Tamoxifen


subject: UNII:N9J26R98VQ

object_name: type 2 diabetes mellitus


subject: CHEBI:168849


subject: CHEBI:7071

subject_name: DEET


subject: CHEBI:184081

subject_name: Diethyltryptamine


subject: CHEBI:135316

subject_name: Liarozole

object_name: Collodion Fetus


subject: CHEBI:135316

object_name: Harlequin Fetus


subject: CHEBI:33375

subject_name: Gadolinium

object_name: glioma


subject: CHEMBL.COMPOUND:CHEMBL1232993

subject_name: GADOLINIUM


subject: CHEBI:63632

subject_name: Topotecan


subject: UMLS:C3641622

subject_name: Amnion-derived Cellular Cytokine Solution

object_name: gingivitis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Transsexualism


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:6904

subject_name: Metoprolol

object_name: cardiomyopathy


subject: UMLS:C4743011

object_name: psoriasis


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: lumbar disc herniation


subject: CHEBI:5118

subject_name: Fluoxetine


subject: UNII:Z87O6SM01N

subject_name: BEPIROVIRSEN

object_name: chronic hepatitis B virus infection


subject: UNII:Z87O6SM01N

object_name: hepatitis B


subject: UMLS:C5446710

subject_name: Bepirovirsen


subject: UMLS:C5446710


subject: CHEBI:6933

subject_name: Midodrine

object_name: hypotension


subject: CHEBI:6933

object_name: Hypotension, CTCAE


subject: CHEBI:6933

object_name: Cirrhosis


subject: CHEBI:6933

object_name: liver cirrhosis


subject: CHEBI:6933

object_name: Ascites


subject: CHEBI:6933

object_name: Ascites, CTCAE


subject: CHEBI:6933

object_name: chronic liver failure


subject: CHEBI:47426

subject_name: Furosemide

object_name: preeclampsia/eclampsia 1


subject: CHEBI:47426

object_name: hypertension, pregnancy-induced


subject: CHEBI:47426

object_name: HELLP syndrome


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:7986

object_name: obesity


subject: CHEBI:7986

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest

object_name: uterine fibroid


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:90531

subject_name: Sotrastaurin

object_name: ulcerative colitis


subject: CHEBI:90531

object_name: inflammatory bowel disease 1


subject: UMLS:C2830197


subject: UMLS:C2830197


subject: CHEBI:4974

subject_name: Famciclovir

object_name: Meniere disease


subject: CHEBI:177770

subject_name: Ganetespib

object_name: Advanced lung cancer


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: orthostatic hypotension


subject: UNII:3ZY6J6Z6EE

object_name: Parkinson disease


subject: UNII:F64QU97QCR

subject_name: Dantrolene

object_name: exercise-induced malignant hyperthermia


subject: CHEBI:114785

subject_name: Erlotinib

object_name: neuroendocrine neoplasm


subject: CHEBI:114785

object_name: multiple endocrine neoplasia


subject: CHEBI:114785

object_name: adrenal gland neoplasm


subject: CHEBI:114785

object_name: carcinoid tumor


subject: CHEBI:114785

object_name: Childhood Neuroblastoma


subject: CHEBI:114785

object_name: neuroblastoma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UMLS:C4058551

subject_name: Paliperidone ER

object_name: bipolar disorder


subject: UMLS:C4058551

object_name: mood disorder


subject: CHEBI:60791

subject_name: Xylocard

object_name: Dysphagia


subject: CHEBI:60791

object_name: Dysphagia, CTCAE


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:49603

subject_name: Lapatinib

object_name: bladder tumor


subject: CHEBI:49603

object_name: urinary bladder cancer


subject: CHEBI:49603

object_name: childhood bladder carcinoma


subject: CHEBI:64064

subject_name: Salmeterol

object_name: allergic asthma


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:74824

subject_name: Thr-Ala

object_name: cesarean section; complications


subject: PUBCHEM.COMPOUND:4532223

subject_name: Tantalum


subject: PR:000006886

subject_name: ectodysplasin-A


subject: PR:000016550


subject: UMLS:C5704062

subject_name: Venlafaxine ER

object_name: panic disorder


subject: UMLS:C5704062

object_name: panic disorder 1


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: cardiac arrest


subject: CHEBI:17650

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:3374

subject_name: Capsaicin

object_name: osteoarthritis, knee


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: metastatic colorectal cancer


subject: CHEBI:33699

subject_name: messenger RNA

object_name: melanoma


subject: CHEBI:33699

object_name: colon carcinoma


subject: CHEBI:33699

object_name: colorectal cancer


subject: CHEBI:33699

object_name: colon cancer


subject: CHEBI:33699

object_name: digestive system cancer


subject: CHEBI:33699

object_name: Genitourinary Cancer


subject: CHEBI:33699

object_name: adult hepatocellular carcinoma


subject: CHEBI:33699

object_name: liver cancer


subject: CHEBI:33699

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:33699

object_name: liver carcinoma


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Blau syndrome


subject: UMLS:C4331798

subject_name: Zinc Finger Nuclease ZFN-603

object_name: Human Papillomavirus-Related Malignant Neoplasm


subject: UMLS:C4331799

subject_name: Zinc Finger Nuclease ZFN-758


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: Pregnant


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: Prostate cancer recurrent


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor

object_name: HER2 positive breast carcinoma


subject: CHEBI:50790

object_name: Hormone receptor positive tumor


subject: CHEBI:50790

object_name: Malignant neoplasm of female breast


subject: CHEBI:50790

object_name: Carcinoma breast stage IV


subject: CHEBI:50790

object_name: Hormone receptor positive malignant neoplasm of breast


subject: CHEBI:50790

object_name: breast disorder


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: UNII:CJN36EQM0H


subject: UNII:CJN36EQM0H


subject: UNII:CJN36EQM0H


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist

object_name: Menopause present (finding)


subject: UMLS:C1268855

object_name: Menopause


subject: UMLS:C1268855

object_name: Oestrogen deficiency


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: CHEBI:8774

subject_name: Ramipril

object_name: coronary microvascular disorder


subject: CHEBI:8774

object_name: Increased reactive oxygen species production


subject: CHEBI:35457

subject_name: EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor


subject: CHEBI:35457


subject: UMLS:C0003015


subject: UMLS:C0003015


subject: CHEBI:9927

subject_name: Valsartan


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: UMLS:C0521942


subject: CHEBI:32129

subject_name: diamminesilver(1+) fluoride

object_name: Dental caries in children


subject: CHEBI:49956

subject_name: Xenon

object_name: Alzheimer disease type 1


subject: CHEBI:49956

object_name: Alzheimer disease


subject: UMLS:C3827145

object_name: Advanced Sarcoma of the Extremity


subject: UMLS:C3827145

object_name: Recurrent Sarcoma of the Extremity


subject: UMLS:C3827145

object_name: Advanced Cutaneous Melanoma of the Extremity


subject: UMLS:C3827145

object_name: Recurrent Cutaneous Melanoma of the Extremity


subject: UMLS:C3827145

object_name: Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C3827145

object_name: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C3827145

object_name: Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C3827145

object_name: Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C3827145

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C3827145

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C3827145

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C3827145

object_name: Pathologic Stage IIIC Cutaneous Melanoma AJCC v8


subject: UMLS:C3827145

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: CHEBI:125354

subject_name: Plerixafor

object_name: beta thalassemia


subject: CHEBI:125354

object_name: beta-thalassemia HBB/LCRB


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:75722

subject_name: Tramadol


subject: UMLS:C1360064

subject_name: tramadol 100 MG Oral Tablet


subject: CHEBI:46195

subject_name: Acetaminophen


subject: UNII:GBZ5UC0RME

object_name: Alzheimer disease


subject: UMLS:C1452745

object_name: Hepatic impairment


subject: UMLS:C1452745

object_name: digestive system disorder


subject: UMLS:C1452745

object_name: liver disorder


subject: CHEMBL.COMPOUND:CHEMBL5095290

object_name: influenza


subject: CHEMBL.COMPOUND:CHEMBL5095290

object_name: Influenza due to Influenza virus, type B


subject: CHEMBL.COMPOUND:CHEMBL5095290

object_name: influenza A


subject: CHEBI:135983

subject_name: Teriparatide

object_name: secondary hyperparathyroidism


subject: CHEBI:135983

object_name: autosomal dominant hypocalcemia


subject: CHEBI:135983

object_name: Hypocalcemia


subject: CHEBI:135983

object_name: Serum calcium below normal (finding)


subject: CHEBI:135983

object_name: Hypocalcemia, CTCAE


subject: CHEBI:135983

object_name: Renal rickets


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: B-cell lymphoma refractory


subject: UMLS:C0003442

object_name: T-cell lymphoma refractory


subject: UMLS:C0003442

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C0003442

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:681569


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:36791

subject_name: Escitalopram

object_name: insomnia


subject: CHEBI:36791

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:36791

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: leukopenia


subject: CHEBI:4026

object_name: neutropenia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: UNII:UT99UG9QJX

subject_name: Eflapegrastim


subject: UNII:UT99UG9QJX


subject: UNII:UT99UG9QJX

object_name: Childhood Breast Carcinoma


subject: UNII:UT99UG9QJX

object_name: breast carcinoma


subject: UNII:UT99UG9QJX

object_name: breast cancer


subject: UNII:4B3SC438HI

subject_name: METHYLPHENIDATE HYDROCHLORIDE

object_name: KBG syndrome


subject: UNII:4B3SC438HI

object_name: Attention deficit hyperactivity disorder, combined type


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:6887


subject: UMLS:C4688355

subject_name: Mezagitamab

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: UMLS:C4688355

object_name: Autoimmunity


subject: CHEBI:15422

subject_name: ATP

object_name: asthma


subject: UMLS:C3827143

subject_name: Cetuximab-IRDye 800CW

object_name: High grade glioma


subject: UMLS:C3827143

object_name: malignant glioma


subject: UMLS:C3827143

object_name: glioblastoma


subject: UMLS:C3827143

object_name: Childhood Glioblastoma


subject: UMLS:C3827143

object_name: adult glioblastoma


subject: GTOPDB:13402

subject_name: garadacimab

object_name: interstitial lung disease 1


subject: GTOPDB:13402

object_name: interstitial lung disease 2


subject: UNII:32W6AJL0DY

subject_name: GARADACIMAB


subject: UNII:32W6AJL0DY


subject: UMLS:C5238067

subject_name: Garadacimab


subject: UMLS:C5238067


subject: CHEBI:7465

subject_name: Naltrexone

object_name: migraine


subject: CHEBI:7465

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Neck Carcinoma


subject: UNII:M89N0Q7EQR

object_name: head and neck neoplasm


subject: UNII:M89N0Q7EQR

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:435949

object_name: transitional cell carcinoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: DRUGBANK:DB17523


subject: DRUGBANK:DB17523


subject: CHEBI:3219

subject_name: Bupropion

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90620

subject_name: Vatalanib

object_name: breast neoplasm


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C1524078


subject: CHEBI:63632

subject_name: Topotecan

object_name: leukemia


subject: CHEBI:63632

object_name: childhood leukemia


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863

object_name: EPHA2 Protein Overexpression


subject: UMLS:C4289973

subject_name: Anti-CTLA-4 Monoclonal Antibody

object_name: Adult Solid Neoplasm


subject: UMLS:C4289973


subject: UMLS:C4289973


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:15544

subject_name: Alprostadil

object_name: congenital heart disease


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: hepatitis D


subject: CHEBI:45409

subject_name: Ritonavir


subject: UMLS:C5399992

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5399992

object_name: acute myeloid leukemia


subject: UMLS:C0017007

subject_name: Gamma globulin

object_name: agammaglobulinemia


subject: UMLS:C0017007

object_name: syndromic agammaglobulinemia


subject: UMLS:C0017007

object_name: common variable immunodeficiency


subject: UMLS:C0017007

object_name: Acquired Hypogammaglobulinemia


subject: UNII:HOU4I0G29C

subject_name: Netazepide

object_name: Zollinger-Ellison syndrome


subject: RXCUI:718834

subject_name: Coartem

object_name: malaria


subject: RXCUI:718834

object_name: pneumonia


subject: RXCUI:718834

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEMBL.COMPOUND:CHEMBL4297781

subject_name: PETOSEMTAMAB

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5421047

subject_name: Petosemtamab


subject: CHEMBL.COMPOUND:CHEMBL1201458

subject_name: ETHIODIZED OIL

object_name: liver carcinoma


subject: UMLS:C2699002

subject_name: Prolarix


subject: UNII:MC09H30MFS

subject_name: CARICOTAMIDE


subject: DRUGBANK:DB18950

subject_name: Caricotamide


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: mucositis


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: multiple sclerosis


subject: CHEBI:3160

object_name: Tremor


subject: CHEBI:3160

object_name: Tremor, CTCAE_5


subject: CHEBI:3160

object_name: Tremor, CTCAE_3


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: carpal tunnel syndrome 1


subject: CHEBI:6888

object_name: carpal tunnel syndrome


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:50815

subject_name: Norgestimate

object_name: Drug Interactions


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:27470

subject_name: Folic acid


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Respiratory complication


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:58008990

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:58008990

object_name: lymphoid leukemia


subject: PUBCHEM.COMPOUND:58008990

object_name: plasma cell myeloma


subject: CHEBI:44658

subject_name: okadaic acid

object_name: mumps


subject: CHEBI:44658

object_name: measles


subject: CHEBI:44658

object_name: chickenpox


subject: CHEBI:44658

object_name: rubella


subject: PUBCHEM.COMPOUND:22833655

subject_name: Eriocitrin

object_name: Prediabetes


subject: CHEBI:23965

subject_name: estradiol

object_name: postmenopausal atrophic vaginitis


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: melanoma


subject: CHEBI:50692

subject_name: Mifepristone

object_name: adenomyosis


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: HER2-positive gastric cancer


subject: CHEBI:64816

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:94518

object_name: Deep venous thrombosis


subject: CHEBI:94518

object_name: pulmonary embolism


subject: CHEBI:94518

object_name: myocardial infarction


subject: CHEBI:94518

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:94518

object_name: Myocardial Infarction by ECG Finding


subject: UNII:8F5X4B082E

subject_name: Lixivaptan

object_name: Hyponatremia with normal extracellular fluid volume


subject: CHEBI:173554

subject_name: Ethyl 3-mercaptopropanoic acid

object_name: generalized anxiety disorder


subject: CHEBI:9586

subject_name: Tiagabine


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Hemorrhage


subject: PUBCHEM.COMPOUND:5281767

object_name: Metrorrhagia


subject: PUBCHEM.COMPOUND:5281767

object_name: Break-through bleeding (finding)


subject: CHEBI:94518

object_name: Iron deficiency anemia secondary to chronic blood loss


subject: CHEBI:94518

object_name: Acute posthaemorrhagic anaemia


subject: CHEBI:94518

object_name: osteoarthritis, hip


subject: CHEBI:34574

object_name: Albuminuria


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: CHEBI:167574

subject_name: Semaglutide


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: acute kidney failure


subject: CHEBI:17154

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:17154

object_name: Myocardial injury


subject: CHEBI:17154

object_name: Reperfusion Injury


subject: CHEBI:151315

subject_name: Heparin

object_name: heart disorder


subject: KEGG.COMPOUND:C00374


subject: UMLS:C5783502

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C5783502

object_name: aggressive NK-cell leukemia


subject: UMLS:C5783502

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C5783502

object_name: enteropathy-associated T-cell lymphoma


subject: UMLS:C5783502

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C5783502

object_name: primary cutaneous gamma-delta t-cell lymphoma


subject: UMLS:C5783502

object_name: subcutaneous panniculitis-like T-cell lymphoma


subject: UMLS:C5783502

object_name: monomorphic epitheliotropic intestinal T-cell lymphoma


subject: UMLS:C5783502

object_name: primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma


subject: UMLS:C5783502

object_name: hydroa vacciniforme-like lymphoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: hemorrhoid


subject: CHEBI:6121

object_name: Hemorrhoids, CTCAE 3.0


subject: CHEBI:6121

object_name: Hemorrhoids, CTCAE 5.0


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: pancreatitis


subject: CHEBI:7915

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:7915

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:7915

object_name: pancreatic neoplasm


subject: CHEBI:7915

object_name: exocrine pancreatic carcinoma


subject: CHEBI:7915

object_name: malignant pancreatic neoplasm


subject: CHEBI:7915

object_name: Duodenal Cancer


subject: CHEBI:7915

object_name: carcinoma of duodenum


subject: CHEBI:7915

object_name: duodenum cancer


subject: CHEBI:7915

object_name: carcinoma of the ampulla of vater


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: arthropathy of shoulder region


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: benign prostatic hyperplasia


subject: UMLS:C1704263

subject_name: green tea extract

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1704263

object_name: obesity


subject: UMLS:C1704263

object_name: Obesity, CTCAE


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307


subject: PUBCHEM.COMPOUND:22227703

subject_name: Loteprednol etabonate

object_name: dry eye syndrome


subject: CHEBI:50848

subject_name: Loteprednol


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: anosmia


subject: CHEBI:28939

object_name: Anosmia, CTCAE


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:124959

subject_name: Tilarginine

object_name: pure autonomic failure


subject: UMLS:C0069477


subject: CHEBI:9728

subject_name: Trimethaphan


subject: CHEBI:52575

subject_name: alkylglycerol

object_name: Immune System and Related Disorders


subject: CHEBI:75883

subject_name: monoalkylglycerol


subject: UMLS:C0935953

subject_name: Mobist

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0935953

object_name: Embolism, Tumor


subject: UMLS:C0935953

object_name: Neoplasm Metastasis


subject: UMLS:C4758796

object_name: pancreatic neoplasm


subject: UMLS:C4758796

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4758796

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: PUBCHEM.COMPOUND:9831414


subject: PUBCHEM.COMPOUND:9831414


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:46245

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: osteomyelitis


subject: PUBCHEM.COMPOUND:135512673

object_name: Amputated structure (morphologic abnormality)


subject: PUBCHEM.COMPOUND:135512673

object_name: Diabetes


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: CHEBI:49603

subject_name: Lapatinib

object_name: lung cancer


subject: CHEBI:49603

object_name: lung neoplasm


subject: CHEBI:49603

object_name: lung carcinoma


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: Crohn disease


subject: CHEBI:191088

subject_name: 3-(cyclohexylamino)propanesulfonic acid

object_name: inflammatory bowel disease 1


subject: CHEBI:191088


subject: PUBCHEM.COMPOUND:171558

subject_name: Moduretic

object_name: hypertension


subject: PUBCHEM.COMPOUND:171558

object_name: Hypertension, CTCAE


subject: UMLS:C0128816


subject: UMLS:C0128816


subject: UNII:TA3QN7788D

object_name: triple-negative breast carcinoma


subject: UNII:TA3QN7788D

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:5W8JGG2651

subject_name: Idursulfase

object_name: mucopolysaccharidosis II, dog


subject: UNII:5W8JGG2651

object_name: mucopolysaccharidosis II, Kaka


subject: PR:000008894

subject_name: iduronate 2-sulfatase


subject: PR:000008894


subject: CHEBI:4495

subject_name: Diazoxide

object_name: type 1 diabetes mellitus


subject: CHEBI:9168

subject_name: Sirolimus

object_name: yolk sac tumor


subject: CHEBI:9168

object_name: adult yolk sac tumor


subject: CHEBI:9168

object_name: testicular yolk sac tumor


subject: CHEBI:9168

object_name: ovarian yolk sac tumor


subject: CHEBI:9168

object_name: vaginal yolk sac tumor


subject: CHEBI:9168

object_name: adult germ cell tumor


subject: CHEBI:9168

object_name: germ cell tumor


subject: CHEBI:9168

object_name: childhood germ cell tumor


subject: CHEBI:9168

object_name: Germ Cell Cancer


subject: CHEBI:31347

subject_name: camostat mesylate

object_name: COVID-19 PCR test positive


subject: CHEBI:31347

object_name: SARS-CoV-2 acute respiratory disease


subject: CHEBI:31347

object_name: Coronavinae infectious disease


subject: CHEBI:135632

subject_name: Camostat


subject: CHEBI:135632


subject: CHEBI:135632


subject: UMLS:C0108225

subject_name: Camostat mesylate


subject: UMLS:C0108225


subject: UMLS:C0108225


subject: GTOPDB:8935

subject_name: lenzilumab


subject: CHEMBL.COMPOUND:CHEMBL3707325

subject_name: LENZILUMAB


subject: UMLS:C4087043


subject: UNII:5YSY733NA3

object_name: plasma cell myeloma


subject: UNII:5YSY733NA3

object_name: Plasma cell myeloma refractory


subject: UNII:5YSY733NA3

object_name: Relapse multiple myeloma


subject: UNII:5YSY733NA3

object_name: Plasma cell myeloma recurrent


subject: UMLS:C2987373


subject: UMLS:C2987373


subject: UMLS:C2987373


subject: UMLS:C2987373


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: CHEBI:231614

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:76609

subject_name: Aprocitentan

object_name: resistant hypertension


subject: CHEBI:76609

object_name: Hypertension resistant to conventional therapy


subject: CHEBI:197107

subject_name: Bafetinib

object_name: castration-resistant prostate carcinoma


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: Adherence To Medication Regime


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: immunoglobulin G4-related sclerosing disease


subject: UNII:7D0YB67S97

object_name: Immunoglobulin G4-Related Disease


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: poliomyelitis


subject: UMLS:C1815825

subject_name: NIGELLA Extract


subject: UMLS:C2698199

subject_name: Lovaxin-C

object_name: Neck Carcinoma


subject: UMLS:C2698199

object_name: head and neck neoplasm


subject: UMLS:C2698199

object_name: head and neck cancer


subject: UMLS:C2698199

object_name: cancer


subject: UMLS:C2698199

object_name: neoplasm


subject: UMLS:C2698199

object_name: cervical cancer


subject: UMLS:C2698199

object_name: cervical carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: Stage IV Lung Cancer AJCC v7


subject: MESH:C108494

subject_name: ISIS 3521

object_name: lung cancer


subject: MESH:C108494

object_name: lung neoplasm


subject: MESH:C108494

object_name: lung carcinoma


subject: MESH:C108494

object_name: skin melanoma


subject: CHEBI:39112

subject_name: Bosutinib

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:39112

object_name: Blasts Under 30 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:39112

object_name: Blasts Under 15 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:39112

object_name: Blasts Under 15 Percent of Peripheral Blood White Cells


subject: CHEBI:39112

object_name: Blasts Under 30 Percent of Peripheral Blood White Cells


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: carcinoma of esophagus


subject: UNII:2S9ZZM9Q9V

object_name: esophageal cancer


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Esophageal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stomach cancer


subject: UNII:2S9ZZM9Q9V

object_name: gastric cancer


subject: UMLS:C5784742

subject_name: Anti-FRa ADC IMGN151

object_name: cervical cancer


subject: UMLS:C5784742

object_name: cervical carcinoma


subject: UMLS:C5784742

object_name: endometrial cancer


subject: UMLS:C5784742

object_name: uterine corpus cancer


subject: UMLS:C5784742

object_name: endometrial carcinoma


subject: UMLS:C5784742

object_name: fallopian tube carcinoma


subject: UMLS:C5784742

object_name: fallopian tube cancer


subject: UMLS:C5784742

object_name: primary peritoneal carcinoma


subject: UMLS:C5784742

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C5784742

object_name: peritoneal carcinoma


subject: UMLS:C5784742

object_name: high grade ovarian serous adenocarcinoma


subject: RXCUI:1801231

subject_name: azelastine / fluticasone Nasal Product

object_name: allergic asthma


subject: RXCUI:1801231

object_name: Allergy


subject: RXCUI:1801231

object_name: History of allergies


subject: RXCUI:1801231

object_name: Atopic rhinitis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Recurrent Uterine Corpus Cancer


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Endometrial Endometrioid Adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Endometrial Undifferentiated Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Endometrial Clear Cell Adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Recurrent Endometrial Serous Adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: endometrial squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: squamous cell carcinoma of the corpus uteri


subject: PUBCHEM.COMPOUND:2767

object_name: endometrial mucinous adenocarcinoma


subject: CHEBI:195327

subject_name: Hydroxypropyl betadex

object_name: Niemann-Pick disease, type C1


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Neck Carcinoma


subject: MESH:C520255

object_name: head and neck neoplasm


subject: MESH:C520255

object_name: head and neck cancer


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Primary malignant neoplasm


subject: CHEBI:90001

object_name: cancer


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: systemic mycosis


subject: UMLS:C0013700

subject_name: Egg Proteins

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0013700

object_name: obesity


subject: UMLS:C0013700

object_name: Obesity, CTCAE


subject: UMLS:C0013700

object_name: Prediabetes


subject: CHEBI:6801

subject_name: Metformin

object_name: Overweight or obese


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:10033

subject_name: Warfarin


subject: UMLS:C2348174

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: dental pulp disorder


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: venous thromboembolism


subject: CHEBI:3732

object_name: thrombophilia due to thrombin defect


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Orofacial Pain


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:27306

subject_name: vitamin B6

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:27306

object_name: Dermatologic Complication


subject: CHEBI:27306

object_name: hand-foot syndrome


subject: CHEBI:7772

subject_name: omeprazole

object_name: Diabetes


subject: CHEBI:7772

object_name: diabetes mellitus


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: PUBCHEM.COMPOUND:152165

object_name: Ankle Sprains


subject: CHEBI:95165

object_name: Resectable Head and Neck Squamous Cell Carcinoma


subject: CHEBI:95165

object_name: Human papillomavirus negative squamous cell carcinoma


subject: CHEBI:95165

object_name: Resectable Human Papillomavirus-Independent Mucosal Head and Neck Squamous Cell Carcinoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: non-Hodgkin lymphoma


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:5372


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5556649

subject_name: Anti-KLK2/CD3 Bispecific Antibody JNJ-78278343

object_name: prostate cancer


subject: UMLS:C5556649

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:118676295

subject_name: vicadrostat

object_name: hypertension


subject: PUBCHEM.COMPOUND:118676295

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:118676295

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:118676295

object_name: type 2 diabetes mellitus


subject: UNII:AF4VW4GA3H

subject_name: VICADROSTAT


subject: UNII:AF4VW4GA3H


subject: UNII:AF4VW4GA3H


subject: UNII:AF4VW4GA3H


subject: CHEBI:7774

subject_name: Zofran

object_name: post operative nausea and vomiting


subject: PUBCHEM.COMPOUND:46883775

object_name: osteoarthritis, knee


subject: CHEBI:71219

subject_name: Pazopanib

object_name: colorectal neoplasm


subject: CHEBI:173763

subject_name: Thermophillin

object_name: cancer


subject: CHEBI:173763

object_name: neoplasm


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: PUBCHEM.COMPOUND:23597337


subject: UMLS:C0354641

subject_name: Factor VIII fraction products

object_name: hemophilia A


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Thromboembolism


subject: CHEBI:15365

subject_name: Aspirin

object_name: EXCESS LMW-DNA


subject: CHEBI:15365


subject: PUBCHEM.COMPOUND:2269

object_name: severe acute respiratory syndrome


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: CHEBI:46662

subject_name: mineral


subject: CHEBI:46662


subject: CHEBI:43830

subject_name: Methylthioninium

object_name: urinary tract infection


subject: CHEBI:43830

object_name: Recurrent urinary tract infections


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: borderline personality disorder


subject: CHEBI:7726

subject_name: octreotide

object_name: acromegaly


subject: CHEBI:7726

object_name: Acral overgrowth


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Skeletal muscle damage


subject: CHEBI:28939

object_name: Aseptic inflammation


subject: UNII:F40IRN5981

subject_name: Chiauranib

object_name: ovarian cancer


subject: UNII:F40IRN5981

object_name: ovarian neoplasm


subject: UNII:F40IRN5981

object_name: ovarian carcinoma


subject: CHEBI:135622

subject_name: Besifloxacin

object_name: bacterial conjunctivitis


subject: UNII:KXQ762CQTH

object_name: plasma cell myeloma


subject: UNII:J6U9WP10T7


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: metastatic colorectal cancer


subject: UMLS:C0947677

subject_name: Lipiodol


subject: CHEBI:5000

subject_name: Fenfluramine

object_name: Dravet syndrome, intractable


subject: CHEBI:71219

subject_name: Pazopanib

object_name: renal cell adenocarcinoma


subject: CHEBI:33357

subject_name: hassium atom

object_name: traumatic encephalopathy


subject: CHEBI:74056

subject_name: His-Ser


subject: PR:000008437

subject_name: histidine ammonia-lyase


subject: CHEMBL.COMPOUND:CHEMBL2108758

subject_name: PEPPERMINT OIL

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108758

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL2108758

object_name: colon cancer


subject: CHEMBL.COMPOUND:CHEMBL2108758

object_name: polyp of colon


subject: CHEMBL.COMPOUND:CHEMBL2108758

object_name: Encounter due to family history of colonic polyps


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: euthyroid Graves orbitopathy


subject: UNII:I031V2H011

object_name: disorder of orbital region


subject: UNII:I031V2H011

object_name: eye disorder


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Poisoning by, adverse effect of and underdosing of methylphenidate


subject: CHEBI:5558

subject_name: Guanfacine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:177770

subject_name: Ganetespib

object_name: small cell lung carcinoma


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Late Preterm Birth


subject: CHEBI:87631

subject_name: statin

object_name: sudden sensorineural hearing loss


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:17754

subject_name: Glycerin

object_name: gastroschisis


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: cardiac arrest


subject: CHEBI:177504

object_name: Cardiac Arrest, CTCAE


subject: UMLS:C2092279

subject_name: Sodium Chloride Liquid Injection


subject: UMLS:C2092279


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Epstein-Barr viraemia


subject: UNII:DPT0O3T46P

object_name: EBV Infection


subject: CHEMBL.COMPOUND:CHEMBL3990008

subject_name: TABELECLEUCEL

object_name: nasopharyngeal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3990008

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL3990008


subject: CHEMBL.COMPOUND:CHEMBL3990008


subject: CHEMBL.COMPOUND:CHEMBL3990008

object_name: nasopharyngeal neoplasm


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: PUBCHEM.COMPOUND:53477758

object_name: Coronavinae infectious disease


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Childhood Breast Carcinoma


subject: CHEBI:135515

object_name: breast carcinoma


subject: CHEBI:135515

object_name: breast cancer


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: pancreatic adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C3827143

subject_name: Cetuximab-IRDye 800CW


subject: CHEBI:82339

subject_name: Merphalan

object_name: retinoblastoma


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Vasoplegia


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C5690713


subject: UMLS:C5690453


subject: UNII:I1BSR8FDW9

subject_name: curdlan sulfate

object_name: HIV infection


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Recurrent disease


subject: PUBCHEM.COMPOUND:1805

object_name: Global Relapse in Viscera


subject: PUBCHEM.COMPOUND:1805

object_name: Global Relapse in Lymph Nodes


subject: PUBCHEM.COMPOUND:1805

object_name: Relapse Following Intervention for Kawasaki Disease


subject: PUBCHEM.COMPOUND:1805

object_name: Global Relapse


subject: PUBCHEM.COMPOUND:1805

object_name: Global Relapse in Skin


subject: PUBCHEM.COMPOUND:1805

object_name: Global Relapse in Blood


subject: PUBCHEM.COMPOUND:1805

object_name: Pre T-ALL


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:2948


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Chronic liver disease


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C2826229

object_name: breast neoplasm


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Inflammation


subject: UMLS:C4704928

subject_name: Antibody-Drug Conjugates

object_name: Unresectable Soft Tissue Sarcoma


subject: UMLS:C4704928

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4704928

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEBI:35181


subject: CHEBI:35181


subject: CHEBI:35181


subject: CHEBI:18198

subject_name: 4-amino-4-deoxychorismic acid


subject: CHEBI:18198


subject: CHEBI:18198


subject: CHEBI:157780

subject_name: S-Cysteinosuccinic acid


subject: CHEBI:157780


subject: CHEBI:157780


subject: PR:000022058

subject_name: biodegradative arginine decarboxylase


subject: PR:000022058


subject: PR:000022058


subject: PR:000007791

subject_name: acidic amino acid decarboxylase GADL1


subject: PR:000007791


subject: PR:000007791


subject: PR:000023971

subject_name: biosynthetic arginine decarboxylase


subject: PR:000023971


subject: PR:000023971


subject: UniProtKB:Q7NSA6

subject_name: ADC_CHRVO Acetoacetate decarboxylase (sprot)


subject: UniProtKB:Q7NSA6


subject: UniProtKB:Q7NSA6


subject: PR:000032161

subject_name: antizyme inhibitor 2


subject: PR:000032161


subject: PR:000032161


subject: UniProtKB:D4A693

subject_name: AZIN2_RAT Antizyme inhibitor 2 (sprot)


subject: UniProtKB:D4A693


subject: UniProtKB:D4A693


subject: UMLS:C5667280

subject_name: Ficus septica Leaf-based Supplement FADA

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C5667280

object_name: Carcinoma breast stage IV


subject: UMLS:C5667280

object_name: malignant neoplasm of breast stage IV


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: bariatric surgery candidate


subject: CHEBI:68579

object_name: morbid obesity


subject: CHEBI:233364

subject_name: Bryostatin

object_name: adult lymphoma


subject: CHEBI:233364

object_name: lymphoma


subject: CHEBI:233364

object_name: pediatric lymphoma


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:6121

subject_name: Ketamine

object_name: alcohol withdrawal


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: esophageal squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C1831726

subject_name: RAR-alpha agonist VTP195183

object_name: plasma cell myeloma


subject: UMLS:C1831726


subject: UMLS:C1831726


subject: UMLS:C1831726


subject: PUBCHEM.COMPOUND:25110515

subject_name: Ozanimod

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:25110515

object_name: Alzheimer disease


subject: CHEBI:132592

object_name: prostate cancer


subject: CHEBI:132592

object_name: prostate neoplasm


subject: CHEBI:50099

subject_name: METAXON


subject: CHEBI:50099


subject: UMLS:C0285488

subject_name: CD46 Antigen


subject: UMLS:C0285488


subject: PR:000005008

subject_name: macrophage-capping protein


subject: PR:000005008


subject: PR:000001401

subject_name: membrane cofactor protein


subject: PR:000001401


subject: UMLS:C4547518

object_name: thrombotic thrombocytopenic purpura


subject: UMLS:C5447457

subject_name: Inixaciclib

object_name: Advanced breast cancer


subject: UMLS:C5447457

object_name: Childhood Breast Carcinoma


subject: UMLS:C5447457

object_name: breast carcinoma


subject: UMLS:C5447457

object_name: breast cancer


subject: UMLS:C5447457

object_name: Carcinoma breast stage IV


subject: UMLS:C5447457

object_name: breast neoplasm


subject: CHEBI:74820

subject_name: Ser-Pro

object_name: Malaria, Vivax


subject: CHEBI:80308

subject_name: substance P


subject: PR:000016275

subject_name: trefoil factor 2


subject: UniProtKB:Q03404

subject_name: TFF2_MOUSE Trefoil factor 2 (sprot)


subject: CHEBI:3638

subject_name: Chloroquine

object_name: malaria


subject: CHEBI:131327

object_name: Plasmodium falciparum malaria


subject: CHEBI:131327


subject: CHEBI:2674

subject_name: Amodiaquine


subject: CHEBI:2674


subject: CHEBI:63918

subject_name: Artesunate


subject: PUBCHEM.COMPOUND:688561

subject_name: Procaterol

object_name: Cough


subject: PUBCHEM.COMPOUND:688561

object_name: Cough, CTCAE


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: hypotension


subject: CHEBI:4466

object_name: Hypotension, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: Conn's syndrome


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: head and neck squamous cell carcinoma


subject: CHEBI:31824

subject_name: Mesna

object_name: chronic kidney disease


subject: UMLS:C3896809

subject_name: HDM2 Inhibitor MK-8242

object_name: acute myeloid leukemia


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: cholera


subject: CHEMBL.COMPOUND:CHEMBL2108029

subject_name: ERTUMAXOMAB


subject: CHEMBL.COMPOUND:CHEMBL2108029

object_name: Advanced breast cancer


subject: UMLS:C1723386

subject_name: ertumaxomab


subject: UMLS:C1723386


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:91464


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:177770

subject_name: Ganetespib

object_name: Childhood Breast Carcinoma


subject: CHEBI:177770

object_name: breast carcinoma


subject: CHEBI:177770

object_name: breast cancer


subject: UMLS:C0717823

subject_name: hydrochlorothiazide / irbesartan

object_name: hypertension


subject: UMLS:C0717823

object_name: Hypertension, CTCAE


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Non-small cell carcinoma


subject: UMLS:C3641122


subject: UMLS:C4751872

subject_name: Ampicillin only product

object_name: Preterm labor with preterm delivery


subject: UMLS:C4751872

object_name: Prolonged premature rupture of membranes


subject: UMLS:C2095775

subject_name: ampicillins


subject: UMLS:C2095775


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: PUBCHEM.COMPOUND:132201704

object_name: Hepatic impairment


subject: UMLS:C3274549

object_name: melanoma


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: Postoperative ileus


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Ovarian neoplasms malignant (excl germ cell)


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:39501

subject_name: trientine

object_name: Carcinoma of peritoneum


subject: CHEBI:39501

object_name: peritoneal carcinoma


subject: CHEBI:39501

object_name: fallopian tube carcinoma


subject: CHEBI:39501

object_name: fallopian tube cancer


subject: CHEBI:39501


subject: CHEBI:7009

subject_name: Moxonidine

object_name: atrial fibrillation


subject: CHEBI:7009

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:7009

object_name: Atrial Fibrillation, CTCAE


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Advanced cancer


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: diffuse large B-cell lymphoma


subject: UMLS:C2346821

object_name: primary mediastinal large B-cell lymphoma


subject: CHEBI:65415

subject_name: Antroquinonol

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: HIV infection


subject: CHEBI:473990

subject_name: Entecavir


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: Solid Neoplasm


subject: UNII:96265TNH2R

object_name: pancreatic neoplasm


subject: UNII:96265TNH2R

object_name: exocrine pancreatic carcinoma


subject: UNII:96265TNH2R

object_name: malignant pancreatic neoplasm


subject: UNII:96265TNH2R

object_name: head and neck cancer


subject: UNII:96265TNH2R

object_name: squamous cell lung carcinoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:2RLB4T4GW2


subject: UMLS:C5926549

subject_name: SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2705


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain on the left


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain occurs with urination


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain occurs with bowel movement


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain decreasing in severity


subject: PUBCHEM.COMPOUND:249921

object_name: Pelvic pain female


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain increasing in severity


subject: PUBCHEM.COMPOUND:249921

object_name: male pelvic pain


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain to the rear


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain on the right


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain decreasing in frequency


subject: PUBCHEM.COMPOUND:249921

object_name: Pelvic pain


subject: PUBCHEM.COMPOUND:249921

object_name: Pelvic Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain causes awakening at night


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain increasing in frequency


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain occurs with intercourse


subject: PUBCHEM.COMPOUND:249921

object_name: pelvic pain in front


subject: PUBCHEM.COMPOUND:249921

object_name: Deep endometriosis


subject: CHEBI:89642

subject_name: Gestrinone

object_name: pelvic pain on the left


subject: CHEBI:89642

object_name: pelvic pain occurs with urination


subject: CHEBI:89642

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:89642

object_name: pelvic pain decreasing in severity


subject: CHEBI:89642

object_name: Pelvic pain female


subject: CHEBI:89642

object_name: pelvic pain increasing in severity


subject: CHEBI:89642

object_name: male pelvic pain


subject: CHEBI:89642

object_name: pelvic pain to the rear


subject: CHEBI:89642

object_name: pelvic pain on the right


subject: CHEBI:89642

object_name: pelvic pain decreasing in frequency


subject: CHEBI:89642

object_name: Pelvic pain


subject: CHEBI:89642

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:89642

object_name: pelvic pain causes awakening at night


subject: CHEBI:89642

object_name: pelvic pain increasing in frequency


subject: CHEBI:89642

object_name: pelvic pain occurs with intercourse


subject: CHEBI:89642

object_name: pelvic pain in front


subject: CHEBI:89642

object_name: Deep endometriosis


subject: CHEBI:49325

subject_name: oral contraceptive


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: CHEBI:64354

subject_name: Metolazone

object_name: Heart Failure, CTCAE


subject: UMLS:C3179472

object_name: Hepatic impairment


subject: UMLS:C1959558


subject: CHEBI:10034

subject_name: warfarin sodium

object_name: Deep vein thrombosis of lower limb


subject: CHEBI:10034

object_name: LOWER EXTREMITY DEEP VENOUS THROMBOSIS RECURRENT


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol

object_name: acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: latent tuberculosis infection


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C4045694

object_name: type 2 diabetes mellitus


subject: UMLS:C4045694

object_name: chronic kidney disease


subject: UMLS:C4045694

object_name: Chronic Kidney Disease, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: metastatic colorectal cancer


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: CHEBI:64312

subject_name: Memantine

object_name: Pick Complex


subject: CHEBI:64312

object_name: frontotemporal dementia


subject: CHEBI:64312

object_name: Pick disease


subject: UMLS:C3274916

subject_name: GRASPA

object_name: triple-negative breast carcinoma


subject: UMLS:C3274916

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C0592151

subject_name: synacthen

object_name: adrenocortical insufficiency


subject: UMLS:C0592151

object_name: Adrenal Insufficiency, CTCAE


subject: UMLS:C0592151

object_name: hypopituitarism


subject: UMLS:C0592151

object_name: Hypopituitarism, CTCAE


subject: CHEBI:3901

subject_name: Tetracosactide


subject: CHEBI:3901


subject: UMLS:C4085973

object_name: ERBB2 mutation-related tumors


subject: CHEBI:6931

subject_name: Midazolam

object_name: respiratory syncytial virus infectious disease


subject: UNII:5L3SX16QBQ

object_name: asthma


subject: CHEBI:73727


subject: CHEBI:73727

object_name: coronary artery disorder


subject: CHEBI:73727

object_name: coronary atherosclerosis


subject: CHEBI:31701

subject_name: Iobitridol

object_name: type 2 diabetes mellitus


subject: UMLS:C0021761

object_name: plasma cell myeloma


subject: UMLS:C2697511


subject: PUBCHEM.COMPOUND:44602504

subject_name: Etrasimod

object_name: inflammatory bowel disease


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Pediatric Obesity


subject: CHEBI:15377

subject_name: Water


subject: PUBCHEM.COMPOUND:5066234

subject_name: Sucralose


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation


subject: CHEBI:17992

subject_name: Sucrose


subject: PUBCHEM.COMPOUND:46200932

subject_name: Balovaptan

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:46200932

object_name: autism


subject: PUBCHEM.COMPOUND:46200932

object_name: autism spectrum disorder


subject: UNII:RAX5D5AGV6


subject: UNII:RAX5D5AGV6


subject: UNII:RAX5D5AGV6


subject: CHEBI:50217

subject_name: selegiline

object_name: major depressive disorder


subject: MESH:C000627770

subject_name: folfirinox

object_name: Pancreatic cancer non-resectable


subject: CHEBI:53766

subject_name: Acenocoumarol

object_name: Prosthetic cardiac valve thrombosis


subject: CHEBI:53766

object_name: prosthetic valve malfunction


subject: CHEBI:53766

object_name: stroke disorder


subject: CHEBI:53766

object_name: cerebrovascular disorder


subject: PUBCHEM.COMPOUND:2269

object_name: chronic rhinosinusitis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:16796

subject_name: Melatonin

object_name: Edema


subject: CHEBI:16796

object_name: Dentofacial Deformities


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:16129681

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: PUBCHEM.COMPOUND:53481605


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C0308312

subject_name: amino acid solution

object_name: Hypothermia due to exposure


subject: UMLS:C0308312

object_name: Hypothermia


subject: UMLS:C0308312

object_name: Hypothermia, CTCAE


subject: UMLS:C0042210

subject_name: Vaccines

object_name: non-small cell lung carcinoma


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: PUBCHEM.COMPOUND:136033680

subject_name: Poly(ICLC)


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:45783

subject_name: Imatinib

object_name: fallopian tube carcinoma


subject: CHEBI:45783

object_name: fallopian tube cancer


subject: UMLS:C4053607

object_name: metastatic colorectal cancer


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: von Hippel-Lindau disease


subject: UNII:7K28NB895L

object_name: hereditary clear cell renal cell carcinoma


subject: UNII:7K28NB895L

object_name: Retinal angiomatous proliferation


subject: UNII:7K28NB895L

object_name: pheochromocytoma-paraganglioma


subject: UNII:7K28NB895L

object_name: endolymphatic sac tumor


subject: UNII:7K28NB895L

object_name: primitive neuroectodermal tumor


subject: UNII:7K28NB895L

object_name: Neuroendocrine tumor of pancreas


subject: UNII:7K28NB895L

object_name: peripheral primitive neuroectodermal tumor


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor

object_name: liver cirrhosis


subject: CHEBI:49200

object_name: portal hypertension


subject: UMLS:C0358591

subject_name: Proton Pump Inhibitors


subject: UMLS:C0358591


subject: UMLS:C3540020

subject_name: Proton pump inhibitors for peptic ulcer and GORD


subject: UMLS:C3540020


subject: PUBCHEM.COMPOUND:9935793

subject_name: Clopidogrel Aspirin

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:9935793

object_name: coronary atherosclerosis


subject: CHEBI:125354

subject_name: Plerixafor

object_name: ovarian serous adenocarcinoma


subject: CHEBI:125354


subject: CHEBI:125354

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:6504

object_name: small cell lung carcinoma


subject: UNII:Q8MI0X869M

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Post-Operative Pain